Sign In
Buy ME
$0.606
+0 (+0%)
At Close: Sep 16, 2025
Barrack, Rodos & Bacine Is Investigating 23andMe Holding Co.
09:30am, Tuesday, 24'th Sep 2024
PHILADELPHIA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine is investigating 23andMe Holding Co. (NASDAQ: ME) regarding the mass resignation of all of the independent memb
NEW YORK, NY / ACCESSWIRE / September 23, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into 23andMe Holding Co. (NASDAQ:ME) regarding whether the board of d
Barrack, Rodos & Bacine Is Investigating 23andMe Holding Co.
11:45am, Monday, 23'rd Sep 2024
PHILADELPHIA, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine is investigating 23andMe Holding Co. (NASDAQ: ME) regarding the mass resignation of all of the independent memb
Barrack, Rodos & Bacine Is Investigating 23andMe Holding Co.
10:00am, Monday, 23'rd Sep 2024
PHILADELPHIA, PA / ACCESSWIRE / September 23, 2024 / The law firm of Barrack, Rodos & Bacine is investigating 23andMe Holding Co. (NASDAQ:ME) regarding the mass resignation of all of the independent m
NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into 23andMe Holding Co. (NASDAQ:ME) regarding whether the board of direc
NEW YORK, Sept. 21, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into 23andMe Holding Co. (NASDAQ:ME) regarding whether the board of direc
NEW YORK, NY / ACCESSWIRE / September 20, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into 23andMe Holding Co. (NASDAQ:ME) regarding whether the board of d
23andMe directors resign as the CEO of the genetic-testing company seeks to take it private
04:46am, Friday, 20'th Sep 2024
All of 23andMe's independent directors resigned from its board this week, a rare move that marks the latest challenge for the genetic-testing company.
NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into 23andMe Holding Co. (NASDAQ:ME) regarding whether the board of d
23andMe faces Nasdaq delisting after its entire board resigns
02:40pm, Thursday, 19'th Sep 2024
CNBC's Deidre Bosa joins 'The Exchange' to report on the latest drama in 23andMe.
23andMe faces Nasdaq delisting
12:48pm, Thursday, 19'th Sep 2024
CNBC's Deidre Bosa joins 'Money Movers' to discuss the latest updates on 23andMe's, following the exodus of several independent board members.
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating claims on behalf of investors in 23andMe Holding Co. (NASDAQ: ME) concerning the offer to acquire 23andMe by its controlli
How 23andMe Went From Market Darling to Losing Its Entire Board
10:43am, Thursday, 19'th Sep 2024
The genetic-testing company's entire board resigned in protest of its CEO's buy-out offer.
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into 23andMe Holding Co. (NASDAQ:ME) regarding whether the board of direc
All 23andMe board members but CEO resign over no adequate buyout offers
01:48pm, Wednesday, 18'th Sep 2024
The board has rejected both of Anne Wojcicki's buyout proposals to save the struggling genetics company
